Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
8don MSN
Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...
Non-alcoholic fatty liver disease has no early signs. Is your liver at risk? Expert reveals these simple tests could save your life!
Otherwise, it would lead to diseases like acute (sudden) hepatitis (inflammation), chronic (long duration) hepatitis, fatty ...
A study revealed that about 84 per cent of Information Technology (IT) employees have Metabolic Dysfunction-Associated Fatty ...
Asian News International on MSN3d
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASHShilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
News-Medical.Net on MSN8d
Asah1 gene plays key role in preventing progression of nonalcoholic fatty liver diseaseInvestigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...
About 25% of NAFLD patients progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver fibrosis), which can lead to cirrhosis or even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback